Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;14(12):2694.
doi: 10.3390/pharmaceutics14122694.

Synthesis and Cytotoxicity Assessment of Citrate-Coated Calcium and Manganese Ferrite Nanoparticles for Magnetic Hyperthermia

Affiliations

Synthesis and Cytotoxicity Assessment of Citrate-Coated Calcium and Manganese Ferrite Nanoparticles for Magnetic Hyperthermia

Raquel G D Andrade et al. Pharmaceutics. .

Abstract

Calcium-doped manganese ferrite nanoparticles (NPs) are gaining special interest in the biomedical field due to their lower cytotoxicity compared with other ferrites, and the fact that they have improved magnetic properties. Magnetic hyperthermia (MH) is an alternative cancer treatment, in which magnetic nanoparticles promote local heating that can lead to the apoptosis of cancer cells. In this work, manganese/calcium ferrite NPs coated with citrate (CaxMn1-xFe2O4 (x = 0, 0.2, 1), were synthesized by the sol-gel method, followed by calcination, and then characterized regarding their crystalline structure (by X-ray diffraction, XRD), size and shape (by Transmission Electron Microscopy, TEM), hydrodynamic size and zeta potential (by Dynamic Light Scattering, DLS), and heating efficiency (measuring the Specific Absorption Rate, SAR, and Intrinsic Loss Power, ILP) under an alternating magnetic field. The obtained NPs showed a particle size within the range of 10 nm to 20 nm (by TEM) with a spherical or cubic shape. Ca0.2Mn0.8Fe2O4 NPs exhibited the highest SAR value of 36.3 W/g at the lowest field frequency tested, and achieved a temperature variation of ~7 °C in 120 s, meaning that these NPs are suitable magnetic hyperthermia agents. In vitro cellular internalization and cytotoxicity experiments, performed using the human cell line HEK 293T, confirmed cytocompatibility over 0-250 µg/mL range and successful internalization after 24 h. Based on these studies, our data suggest that these manganese-calcium ferrite NPs have potential for MH application and further use in in vivo systems.

Keywords: calcium-doped manganese ferrite; cancer treatment; cellular internalization; magnetic hyperthermia; magnetic nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
XRD diffraction patterns for CaxMn1-xFe2O4 ferrites: (a) x = 0; (b) x = 0.2; (c) x = 1, and fitted patterns obtained through Rietveld refinement.
Figure 2
Figure 2
TEM images of MnFe2O4 (a), Ca0.2Mn0.8Fe2O4 (b) and CaFe2O4 (c) NPs and corresponding histograms of size distribution (df).
Figure 3
Figure 3
Hydrodynamic size, PDI value (a) and zeta potential (b) of the bare and citrate-functionalized CaxMn1-xFe2O4 NPs at 0.01 mg/mL in phosphate buffer pH 7.4. Each value represents the mean ± SD (SD: standard deviation) of two or three independent measurements. Abbreviations: x = 0 + cit, x = 0.2 + cit and x = 1 + cit are citrate−functionalized MnFe2O4, Ca0.2Mn0.8Fe2O4 and CaFe2O4 nanoparticles, respectively.
Figure 4
Figure 4
Values of SAR (a), ILP (b) of citrate-functionalized NPs and variation of temperature (ΔT) over time (t) of MnFe2O4 (c), and Ca0.2Mn0.8Fe2O4 NPs (d), under an AMF at different conditions below the biological acceptance limit (HAC × f = 2 × 109 A m−1 s−1). Abbreviations: x = 0 + cit, x = 0.2 + cit and x = 1 + cit are citrate-functionalized MnFe2O4, Ca0.2Mn0.8Fe2O4, and CaFe2O4 nanoparticles, respectively.
Figure 5
Figure 5
In vitro cytotoxicity in HEK 293T cells of citrate-functionalized Ca-Mn ferrite NPs. Cell viability was assessed by MTT assay in HEK 293T cells incubated with four different concentrations of NPs (100, 150, 200, 250 µg/mL) for 24 h (a) and 48 h (b). Untreated cells at 24 h and 48 h were used as a negative control (100% viable cells). Data are expressed as the mean of three independent experiments (n = 3). Two-way ANOVA assessed by Tukey’s multiple comparison test indicates no statistically significant differences between the groups tested, denoted as ns p > 0.05. Abbreviations: x = 0 + cit, x = 0.2 + cit and x = 1 + cit are citrate-functionalized MnFe2O4, Ca0.2Mn0.8Fe2O4 and CaFe2O4 nanoparticles, respectively.
Figure 6
Figure 6
Bright field image of HEK 293T cells containing Ca0.2Mn0.8Fe2O4 NPs (a), cellular nucleus stained with DAPI (blue) (b), NPs coupled with CF (green) (c), and overlay of DAPI fluorescence and fluorescence of CF coupled to the NPs (d). The white arrows indicate agglomerates of NPs inside the cell. Images were obtained by fluorescence microscopy using a 40× objective. The scale bar corresponds to 20 µm and all images have the same scale.

References

    1. Zugazagoitia J., Guedes C., Ponce S., Ferrer I., Molina-Pinelo S., Paz-Ares L. Current Challenges in Cancer Treatment. Clin. Ther. 2016;38:1551–1566. doi: 10.1016/j.clinthera.2016.03.026. - DOI - PubMed
    1. Pucci C., Martinelli C., Ciofani G. Innovative Approaches for Cancer Treatment: Current Perspectives and New Challenges. Ecancermedicalscience. 2019;13:961. doi: 10.3332/ecancer.2019.961. - DOI - PMC - PubMed
    1. Kandasamy G., Maity D. Recent Advances in Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for in Vitro and in Vivo Cancer Nanotheranostics. Int. J. Pharm. 2015;496:191–218. doi: 10.1016/j.ijpharm.2015.10.058. - DOI - PubMed
    1. Palanisamy S., Wang Y.M. Superparamagnetic Iron Oxide Nanoparticulate System: Synthesis, Targeting, Drug Delivery and Therapy in Cancer. Dalt. Trans. 2019;48:9490–9515. doi: 10.1039/C9DT00459A. - DOI - PubMed
    1. Healy S., Bakuzis A.F., Goodwill P.W., Attaluri A., Bulte J.W.M., Ivkov R. Clinical Magnetic Hyperthermia Requires Integrated Magnetic Particle Imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2022;14:e1779. doi: 10.1002/wnan.1779. - DOI - PMC - PubMed

LinkOut - more resources